Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
6
×
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
6
×
san francisco blog main
san francisco top stories
biotech
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alnylam pharmaceuticals
celgene
gene therapy
hemophilia
pfizer
biogen
biomarin pharmaceutical
cancer
drug prices
fda
ipo
medicare
What
gene
6
×
bio
drug
roundup
therapy
fda
help
long
medicine
moves
patients
prices
advanced
alnylam
alnylam’s
alzheimer’s
approval
approves
aren’t
becker
bff
billions
cells
companies
conference
crude
cutting
deals
despite
developers
devoted
different
disease
dollars
drugs
easl
eaton
edge
effects
ema
Language
Current search:
" national blog main "
×
gene
×
" san diego top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More